Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial (Q90465416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

main subject

phase III clinical trial

1 reference

inferred from title

author

Stephanie A Smith-Warner

12

object named as

Stephanie Warner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1

John H Beigel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Josalyn Cho

4

0 references

author name string

Evgenia Aga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Marie-Carmelle Elie-Turenne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Pablo Tebas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Carol L Clark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Jordan P Metcalf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Caroline Ozment

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Kanakatte Raviprakash

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Joy Beeler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

H Preston Holley

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Carla Chorley

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

H Clifford Lane

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Michael D Hughes

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Richard T Davey

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

IRC005 Study Team

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

30 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

941-950

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31582360%20AND%20SRC:MED&resulttype=core&format=json

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

14 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Polyclonal and monoclonal antibodies for the treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

The Pediatric Early Warning System score: a severity of illness score to predict urgent medical need in hospitalized children.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Treatment with convalescent plasma for influenza A (H5N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Outcomes of adults hospitalised with severe influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

The role of adjuvant immunomodulatory agents for treatment of severe influenza

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2819%2930199-7

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31582360

12 December 2020